We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+45.29%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$483M
AUM Growth
+$23M
(+5%)
Cap. Flow
-$62.1M
Cap. Flow
% of AUM
-12.86%
Top 10 Holdings %
Top 10 Hldgs %
9.87%
Holding
378
New
132
Increased
14
Reduced
97
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLX Energy Services
KLXE
|
+$3.31M |
| 2 |
Par Pacific Holdings
PARR
|
+$3.1M |
| 3 |
A10 Networks
ATEN
|
+$3.05M |
| 4 |
Federal Signal
FSS
|
+$2.71M |
| 5 |
Tidewater
TDW
|
+$2.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
+$5.93M |
| 2 |
Cogent Biosciences
COGT
|
+$5.04M |
| 3 |
Lantheus
LNTH
|
+$4.84M |
| 4 |
Sensus Healthcare
SRTS
|
+$4.1M |
| 5 |
Cytokinetics
CYTK
|
+$3.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.56% |
| 2 | Industrials | 17.86% |
| 3 | Technology | 16.26% |
| 4 | Energy | 11.48% |
| 5 | Financials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
American Eagle Outfitters
AEO
$2.97B
| $2.15M | 0.44% |
+153,654
| New | +$1.97M |
|
|
PR
77
Permian Resources
PR
$17B
| $2.14M | 0.44% |
+228,098
| New | +$2.18M |
|
78
Covenant Logistics
CVLG
$879M
| $2.14M | 0.44% |
123,706
-52,438
| -30% | -$940K |
|
|
VTYX
79
DELISTED
Ventyx Biosciences
VTYX
| $2.13M | 0.44% |
64,927
-18,311
| -22% | -$542K |
|
80
Northern Oil and Gas
NOG
$2.21B
| $2.12M | 0.44% |
68,869
-14,598
| -17% | -$491K |
|
81
Mammoth Energy Services
TUSK
$142M
| $2.11M | 0.44% |
244,508
-145,276
| -37% | -$827K |
|
82
Preformed Line Products
PLPC
$2.25B
| $2.11M | 0.44% |
25,343
| – | – |
|
83
Nordic American Tanker
NAT
$1.36B
| $2.1M | 0.44% |
687,541
-241,581
| -26% | -$779K |
|
84
Actinium Pharmaceuticals
ATNM
$24.7M
| $2.1M | 0.43% |
+197,021
| New | +$2M |
|
85
Sanmina
SANM
$11B
| $2.09M | 0.43% |
36,491
-27,780
| -43% | -$1.64M |
|
86
Halozyme
HALO
$10.2B
| $2.09M | 0.43% |
+36,732
| New | +$1.88M |
|
87
Madrigal Pharmaceuticals
MDGL
$11.8B
| $2.09M | 0.43% |
+7,198
| New | +$704K |
|
88
Rayonier Advanced Materials
RYAM
$618M
| $2.08M | 0.43% |
+216,821
| New | +$1.38M |
|
89
Neuronetics
STIM
$157M
| $2.08M | 0.43% |
+302,560
| New | +$1.43M |
|
90
Harmonic Inc
HLIT
$1.27B
| $2.08M | 0.43% |
158,547
-152,656
| -49% | -$2.13M |
|
91
Emcor
EME
$35.7B
| $2.08M | 0.43% |
+14,022
| New | +$1.99M |
|
92
Urban Outfitters
URBN
$6.65B
| $2.06M | 0.43% |
+86,339
| New | +$2.15M |
|
93
Magnite
MGNI
$3.48B
| $2.06M | 0.43% |
+194,204
| New | +$1.77M |
|
94
Ardelyx
ARDX
$1.2B
| $2.06M | 0.43% |
+721,598
| New | +$1.22M |
|
95
TG Therapeutics
TGTX
$7.59B
| $1.96M | 0.41% |
+165,447
| New | +$1.2M |
|
96
Evolution Petroleum
EPM
$127M
| $1.95M | 0.4% |
257,952
-87,008
| -25% | -$654K |
|
97
Calix
CALX
$2.36B
| $1.94M | 0.4% |
28,279
-334
| -1% | -$22.4K |
|
98
Inspire Medical Systems
INSP
$1.7B
| $1.93M | 0.4% |
+7,648
| New | +$1.63M |
|
99
Northeast Bank
NBN
$1.14B
| $1.92M | 0.4% |
45,541
| – | – |
|
100
Esquire Financial Holdings
ESQ
$1.14B
| $1.91M | 0.4% |
44,230
-7,988
| -15% | -$339K |
|
Similar funds
RWM
MCM
HP
OMG
ICCFIA
WFAL
WCM
TSS
EAM Investors's Q4 2022 Portfolio in Review
As of Q4 2022, EAM Investors held 378 positions worth $483M, up 5% from $460M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
EAM Investors withdrew a net $62.1M in Q4 2022, closing 129 positions and reducing 97 holdings. Its most notable exit was Concert Pharmaceuticals, Inc., an estimated $5.93M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Industrials and Technology.
Against the trend, EAM Investors opened a new position in KLX Energy Services worth $4.07M.
- EAM Investors's largest Q4 2022 buy was KLX Energy Services: 234,913 shares worth $4.07M.
- EAM Investors added most to Modine Manufacturing in Q4 2022, an estimated $1.28M increase.
- EAM Investors's biggest Q4 2022 reduction was Aehr Test Systems, cutting an estimated $3.09M.
- EAM Investors fully exited Concert Pharmaceuticals, Inc. in Q4 2022, selling an estimated $5.93M.
- EAM Investors's ten largest holdings make up 9.9% of its $483M portfolio in Q4 2022.
- EAM Investors opened 132 new positions and closed 129 in Q4 2022.
- EAM Investors's portfolio value rose 5% quarter-over-quarter to $483M.
Based on EAM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.